Cargando…
MUC1 deficiency mediates corticosteroid resistance in chronic obstructive pulmonary disease
BACKGROUND: Lung inflammation in COPD is poorly controlled by inhaled corticosteroids (ICS). Strategies to improve ICS efficacy or the search of biomarkers who may select those patients candidates to receive ICS in COPD are needed. Recent data indicate that MUC1 cytoplasmic tail (CT) membrane mucin...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247701/ https://www.ncbi.nlm.nih.gov/pubmed/30458870 http://dx.doi.org/10.1186/s12931-018-0927-4 |
_version_ | 1783372535607328768 |
---|---|
author | Milara, Javier Díaz-Platas, Lucía Contreras, Sonia Ribera, Pilar Roger, Inés Ballester, Beatriz Montero, Paula Cogolludo, Ángel Morcillo, Esteban Cortijo, Julio |
author_facet | Milara, Javier Díaz-Platas, Lucía Contreras, Sonia Ribera, Pilar Roger, Inés Ballester, Beatriz Montero, Paula Cogolludo, Ángel Morcillo, Esteban Cortijo, Julio |
author_sort | Milara, Javier |
collection | PubMed |
description | BACKGROUND: Lung inflammation in COPD is poorly controlled by inhaled corticosteroids (ICS). Strategies to improve ICS efficacy or the search of biomarkers who may select those patients candidates to receive ICS in COPD are needed. Recent data indicate that MUC1 cytoplasmic tail (CT) membrane mucin can mediate corticosteroid efficacy in chronic rhinosinusitis. The objective of this work was to analyze the previously unexplored role of MUC1 on corticosteroid efficacy in COPD in vitro and in vivo models. METHODS: MUC1-CT expression was measured by real time PCR, western blot, immunohistochemistry and immunofluorescence. The inflammatory mediators IL-8, MMP9, GM-CSF and MIP3α were measured by ELISA. The effect of MUC1 on inflammation and corticosteroid anti-inflammatory effects was measured using cell siRNA in vitro and Muc1-KO in vivo animal models. RESULTS: MUC1-CT expression was downregulated in lung tissue, bronchial epithelial cells and lung neutrophils from smokers (n = 11) and COPD (n = 11) patients compared with healthy subjects (n = 10). MUC1 was correlated with FEV1% (ρ = 0.7479; p < 0.0001) in smokers and COPD patients. Cigarette smoke extract (CSE) decreased the expression of MUC1 and induced corticosteroid resistance in human primary bronchial epithelial cells and human neutrophils. MUC1 Gene silencing using siRNA-MUC1 impaired the anti-inflammatory effects of dexamethasone and reduced glucocorticoid response element activation. Dexamethasone promoted glucocorticoid receptor alpha (GRα) and MUC1-CT nuclear translocation and co-localization that was inhibited by CSE. Lung function decline and inflammation induced by lipopolysaccharide and cigarette smoke in Muc1 KO mice was resistant to dexamethasone. CONCLUSIONS: These results confirm a role for MUC1-CT mediating corticosteroid efficacy in COPD. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12931-018-0927-4) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6247701 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-62477012018-11-26 MUC1 deficiency mediates corticosteroid resistance in chronic obstructive pulmonary disease Milara, Javier Díaz-Platas, Lucía Contreras, Sonia Ribera, Pilar Roger, Inés Ballester, Beatriz Montero, Paula Cogolludo, Ángel Morcillo, Esteban Cortijo, Julio Respir Res Research BACKGROUND: Lung inflammation in COPD is poorly controlled by inhaled corticosteroids (ICS). Strategies to improve ICS efficacy or the search of biomarkers who may select those patients candidates to receive ICS in COPD are needed. Recent data indicate that MUC1 cytoplasmic tail (CT) membrane mucin can mediate corticosteroid efficacy in chronic rhinosinusitis. The objective of this work was to analyze the previously unexplored role of MUC1 on corticosteroid efficacy in COPD in vitro and in vivo models. METHODS: MUC1-CT expression was measured by real time PCR, western blot, immunohistochemistry and immunofluorescence. The inflammatory mediators IL-8, MMP9, GM-CSF and MIP3α were measured by ELISA. The effect of MUC1 on inflammation and corticosteroid anti-inflammatory effects was measured using cell siRNA in vitro and Muc1-KO in vivo animal models. RESULTS: MUC1-CT expression was downregulated in lung tissue, bronchial epithelial cells and lung neutrophils from smokers (n = 11) and COPD (n = 11) patients compared with healthy subjects (n = 10). MUC1 was correlated with FEV1% (ρ = 0.7479; p < 0.0001) in smokers and COPD patients. Cigarette smoke extract (CSE) decreased the expression of MUC1 and induced corticosteroid resistance in human primary bronchial epithelial cells and human neutrophils. MUC1 Gene silencing using siRNA-MUC1 impaired the anti-inflammatory effects of dexamethasone and reduced glucocorticoid response element activation. Dexamethasone promoted glucocorticoid receptor alpha (GRα) and MUC1-CT nuclear translocation and co-localization that was inhibited by CSE. Lung function decline and inflammation induced by lipopolysaccharide and cigarette smoke in Muc1 KO mice was resistant to dexamethasone. CONCLUSIONS: These results confirm a role for MUC1-CT mediating corticosteroid efficacy in COPD. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12931-018-0927-4) contains supplementary material, which is available to authorized users. BioMed Central 2018-11-20 2018 /pmc/articles/PMC6247701/ /pubmed/30458870 http://dx.doi.org/10.1186/s12931-018-0927-4 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Milara, Javier Díaz-Platas, Lucía Contreras, Sonia Ribera, Pilar Roger, Inés Ballester, Beatriz Montero, Paula Cogolludo, Ángel Morcillo, Esteban Cortijo, Julio MUC1 deficiency mediates corticosteroid resistance in chronic obstructive pulmonary disease |
title | MUC1 deficiency mediates corticosteroid resistance in chronic obstructive pulmonary disease |
title_full | MUC1 deficiency mediates corticosteroid resistance in chronic obstructive pulmonary disease |
title_fullStr | MUC1 deficiency mediates corticosteroid resistance in chronic obstructive pulmonary disease |
title_full_unstemmed | MUC1 deficiency mediates corticosteroid resistance in chronic obstructive pulmonary disease |
title_short | MUC1 deficiency mediates corticosteroid resistance in chronic obstructive pulmonary disease |
title_sort | muc1 deficiency mediates corticosteroid resistance in chronic obstructive pulmonary disease |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247701/ https://www.ncbi.nlm.nih.gov/pubmed/30458870 http://dx.doi.org/10.1186/s12931-018-0927-4 |
work_keys_str_mv | AT milarajavier muc1deficiencymediatescorticosteroidresistanceinchronicobstructivepulmonarydisease AT diazplataslucia muc1deficiencymediatescorticosteroidresistanceinchronicobstructivepulmonarydisease AT contrerassonia muc1deficiencymediatescorticosteroidresistanceinchronicobstructivepulmonarydisease AT riberapilar muc1deficiencymediatescorticosteroidresistanceinchronicobstructivepulmonarydisease AT rogerines muc1deficiencymediatescorticosteroidresistanceinchronicobstructivepulmonarydisease AT ballesterbeatriz muc1deficiencymediatescorticosteroidresistanceinchronicobstructivepulmonarydisease AT monteropaula muc1deficiencymediatescorticosteroidresistanceinchronicobstructivepulmonarydisease AT cogolludoangel muc1deficiencymediatescorticosteroidresistanceinchronicobstructivepulmonarydisease AT morcilloesteban muc1deficiencymediatescorticosteroidresistanceinchronicobstructivepulmonarydisease AT cortijojulio muc1deficiencymediatescorticosteroidresistanceinchronicobstructivepulmonarydisease |